Global Database of Emerging Companies
A powerful research and due diligence tool for investors, entrepreneurs, and business development executives
The OneMedPlace Global Database is the best first stop to learning about the companies and technologies shaping the future of health and medicine. To gain access to full access to this database register.
Searched: Market-Research-Services 1 - 30 of 2452 results Next >
M P Misgav, Israel | Airway management with continuous visualization for single-lung surgery
Mayfield Heights, United States | Global eClinical solutions for the clinical trials industry
San Clemente, CA, USA | Develops invasive tech solutions to alleviate lumbar pain.
Southampton, United Kingdom | Develops novel products for general healthcare application.
San Diego, United States | Targets bioactive signaling lipids for treating a wide range of human disease
1101 BE Amsterdam, The Netherlands | Designing cost-saving technology platform.
Northbrook, IL, USA | Nanotechnology-based life sciences company.
Milford, MA, USA | Develops and sells biological products and services used to accelerate the development and manufacture of diagnostic and therapeutic products.
Sylvania, OH, USA | Biomedical company which created blood volume expander to reverse capillary leak syndrome (CLS).
Princeton,, NJ, USA | Transdermal drug delivery systems for women.
Tampa, FL, USA | Oragenics develops novel products and diagnostics.
Cambridge, MA, USA | Drugs based on synthetic antisense RNA and synthetic peptide.
Vancouver, Canada | SOFIA (â??Surround Optical Fiber Immunoassayâ?) is a unique biomarker detection technology best characterized by its unprecedented 10 zepto-gram (10^-20 g) limit-of-detection and 12-log dynamic range, making it upwards of a million times more sensitive than current industry-best technologies. Bionosis is commercializing SOFIA to significantly enhance biomarker research, and is also developing the technology for clinical application in Alzheimerâ??s Disease and other neurodegenerative diseases.
McLean, VA, USA | Develops and commercialized a new class of immunotherapeutic biologics
Waltham, MA, USA | Autologous neocartilage for tissue repair
Alpharetta, GA, USA | Development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures.
Laval, Canada | Develops medical products from Krill.
Torrance, CA, USA | Emmaus Medical is currently engaged in a Phase III clinical trial of of L-glutamine as a treatment for Sickle Cell Disease and has entered into a collaborative agreement for the research, development and commercialization of regenerative medicine products.
Emerald Hills, United States | Products for safe preparation, delivery and disposal of liquid drugs.
Salt Lake City, UT, USA | Develops and markets surgical devices for soft tissue cutting and coagulation.
Waltham, MA, USA | Diagnosis and treatment of neurological complications of diabetes.
Merrimack, United States | Eleme Medical, an emerging venture backed aesthetics company, is dedicated to providing market-leading technology in all areas of body shaping. SmoothShapes system with Photomology technology is the company\\\\\\\'s preeminent product.
San Jose, CA, USA | DPRs mission is to provide diagnostic radiologists and referring physicians with better patient information, organized in a more efficient manner available at the optimal time which will improve patient care, reduce errors and decrease image exam costs.
Bethesda, MD, USA | Innovative biopharmaceutical products and consulting services.
Developer of products facilitating natural vascular closure and opening vessels.
Austin, United States | Spine diagnostics company focused on spine motion analysis products and services.
Saratoga, CA, USA | Seeks to shift the epidural anesthesia market from devices with unacceptable risk to a proprietary device that improves safety, accuracy, and ease of use during epidural space access.
Palo Alto, CA, USA | Topica is a privately held pharmaceutical company focused on developing luliconazole for the topical prescription treatment of onychomycosis, a fungal infection of the finger and toenails. Topica has exclusive rights in the Americas and Europe to develop and market luliconazole for onychomycosis.
Palo Alto, CA, USA | Develops molecular diagnostics for heart disease
Redwood City, United States | Develops and commercializes technology driven products for aesthetic medicine.